IOVANCE (IOVA) Chief Medical Officer logs RSU vesting, tax-withheld shares in Form 4
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
IOVANCE BIOTHERAPEUTICS, INC. Chief Medical Officer Friedrich Graf Finckenstein reported routine equity compensation activity involving restricted stock units (RSUs). On the transaction date, 7,813 RSUs vested, each converting into one share of common stock. These shares were acquired through an option-style derivative exercise at a stated price of $0.00 per share.
To cover mandatory tax withholding on the vesting, 3,976 common shares were withheld by the company, which the filing clarifies was not an open market sale. After these transactions, the officer directly held 140,111 shares of common stock. The filing also notes 54,691 RSUs remaining from a March 5, 2025 grant, which will vest in equal quarterly installments, providing additional potential future share deliveries as they vest.
Positive
- None.
Negative
- None.
Insider Trade Summary
7,813 shares exercised/converted
Mixed
3 txns
Insider
GRAF FINCKENSTEIN FRIEDRICH
Role
Chief Medical Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 7,813 | $0.00 | -- |
| Exercise | Common Stock | 7,813 | $0.00 | -- |
| Tax Withholding | Common Stock | 3,976 | $4.23 | $17K |
Holdings After Transaction:
Restricted Stock Units — 54,691 shares (Direct, null);
Common Stock — 144,087 shares (Direct, null)
Footnotes (1)
- Represents such shares underlying the restricted stock units ("RSUs") which vested on the transaction date. Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities. Represents the common stock remaining after deducting the common stock withheld for taxes. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The remaining RSUs will vest in equal quarterly installments. Such aggregate number reflects the remainder of such RSUs granted on March 5, 2025, but does not include any other RSUs held by such Reporting Person.
Key Figures
RSUs vested: 7,813 units
Shares withheld for taxes: 3,976 shares
Common shares held after transaction: 140,111 shares
+2 more
5 metrics
RSUs vested
7,813 units
RSUs converted into common stock on transaction date
Shares withheld for taxes
3,976 shares
Mandatory tax withholding on RSU vesting
Common shares held after transaction
140,111 shares
Direct ownership following RSU vesting and tax withholding
Remaining RSUs from March 5, 2025 grant
54,691 units
Scheduled to vest in equal quarterly installments
Exercise price per share
$0.00 per share
Stated price for RSU-related derivative exercise into common stock
Key Terms
Restricted Stock Units, tax withholding, derivative security, vest
4 terms
Restricted Stock Units financial
"The filing reports activity in "Restricted Stock Units" that convert into common stock."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
tax withholding financial
"Shares were withheld by the issuer to satisfy mandatory tax withholding requirements upon vesting."
Tax withholding is the practice of taking a portion of a payment—such as wages, dividends, or sale proceeds—before it reaches the recipient and sending that portion to the tax authority as an advance on the recipient’s eventual tax bill. For investors it matters because withholding reduces immediate cash received and affects after‑tax returns, estimated tax payments, and whether you may owe more or receive a refund when taxes are finally calculated, like having a small automatic savings set aside for your tax bill.
derivative security financial
"The transaction code description notes an exercise or conversion of a derivative security."
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
vest financial
"Footnotes state the RSUs vested on the transaction date and remaining RSUs will vest quarterly."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
What insider stock activity did IOVANCE (IOVA) disclose for its Chief Medical Officer?
IOVANCE’s Chief Medical Officer reported RSU vesting that delivered 7,813 common shares and a related tax-withholding share disposition. The activity reflects routine equity compensation rather than open market buying or selling, according to the detailed transaction codes and accompanying footnotes.
What are the details of the vested and remaining RSUs for IOVANCE (IOVA)?
On the transaction date, 7,813 RSUs vested, each representing one share of common stock. The filing also notes 54,691 RSUs from a March 5, 2025 grant remain outstanding, scheduled to vest in equal quarterly installments over future periods until fully delivered.
How does this IOVANCE (IOVA) Form 4 classify the insider transactions?
The Form 4 classifies one transaction as an RSU-derived exercise acquiring 7,813 common shares and another as a tax-withholding disposition of 3,976 shares. Both are described as derivative-related and compensation-driven events rather than open market purchases or sales of the company’s stock.